anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
atai Life Sciences · pitchdeck

ATAI | Investor Presentation Deck | 31 slides

31 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

ATAI | Investor Presentation Deck | 31 slides

atai Life Sciences · 2023-10
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 31 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 3 slides 100% 3/3 slides 100% 3/3 slides · 9 hits
— 0/3 slides
— 0/3 slides
— 0/3 slides
100% 3/3 slides 33.3% 1/3 slides Solution 2 slides 100% 2/2 slides 100% 2/2 slides · 8 hits
— 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides 100% 2/2 slides Traction 20 slides 100% 20/20 slides 100% 20/20 slides · 111 hits
— 0/20 slides
35% 7/20 slides · 8 hits 20% 4/20 slides 100% 20/20 slides 100% 20/20 slides Roadmap 6 slides 100% 6/6 slides 100% 6/6 slides · 26 hits
— 0/6 slides
16.7% 1/6 slides · 2 hits 33.3% 2/6 slides 100% 6/6 slides
— 0/6 slides

Slide inventory

31
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Problem
02
other
Open slide detailBeat · Problem
03
Slide 03 of the deck.summarize
Open slide detailBeat · ProblemLoop · Cost Of Inaction
04
The chart uses a horizontal bar format to represent the progress of drug candidates through clinical phases.plan_implementation
Open slide detailBeat · SolutionLoop · Cost Of Inaction
05
The slide uses a grid-based timeline/milestone tracker for multiple parallel programs.plan_implementation
Open slide detailBeat · SolutionLoop · Cost Of Inaction
06
transition
Open slide detailBeat · TractionLoop · Quick Win Big Bet
07
Includes a map of global disease burden and specific clinical trial milestones.present_solution
Open slide detailBeat · TractionLoop · Quick Win Big Bet
08
Includes two distinct charts: a scatter/error bar plot for Phase 1 and a bar chart for the Canine Model.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
09
The slide demonstrates an inverted U-shaped dose response curve.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
10
Includes Cohen's d effect sizes and qEEG data markers.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
11
The slide uses a numbered list to highlight key safety findings.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
12
The slide uses a standard clinical trial flow diagram showing randomization into three arms (40mg, 20mg, placebo) over a 6-week period.present_framework
Open slide detailBeat · TractionLoop · Quick Win Big Bet
13
Slide 13 of the deck.transition
Open slide detailBeat · TractionLoop · Quick Win Big Bet
14
Includes a map of global disease burden and key product features.present_solution
Open slide detailBeat · TractionLoop · Quick Win Big Bet
15
Includes a stray chat message overlay in the middle of the slide.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
16
The slide uses a process flow diagram to represent the three parts of the study design.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
17
transition
Open slide detailBeat · TractionLoop · Quick Win Big Bet
18
Includes a map of global disease burden and key epidemiological metrics for OUD.present_solution
Open slide detailBeat · TractionLoop · Quick Win Big Bet
19
The chart displays HCQ-29 subscale scores over time (Pre-dose, Discharge, 1 Month) for four dimensions of craving.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
20
Includes cohort structure, safety monitoring parameters, and specific clinical outcomes regarding plasma levels, adverse events, and QTc prolongation.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
21
The table uses checkmarks to indicate the presence of specific therapeutic benefits across different drug classes.compare_peers
Open slide detailBeat · TractionLoop · Quick Win Big Bet
22
Slide 22 in the deck.transition
Open slide detailBeat · TractionLoop · Quick Win Big Bet
23
Includes a map of global disease burden and key product specs.present_solution
Open slide detailBeat · TractionLoop · Quick Win Big Bet
24
Includes definitions for PK/PD, qEEG, and BID in the footer.show_traction
Open slide detailBeat · TractionLoop · Quick Win Big Bet
25
The slide uses a numbered list to highlight key safety takeaways alongside detailed data tables.analyze_data
Open slide detailBeat · TractionLoop · Quick Win Big Bet
26
Slide 26 of a pitch deck, likely from atai Life Sciences.analyze_data
Open slide detailBeat · Roadmap
27
transition
Open slide detailBeat · Roadmap
28
The slide uses a line chart to show the change in MADRS scores over time across three dosage groups.show_traction
Open slide detailBeat · Roadmap
29
The slide outlines two distinct pivotal studies (COMP 005 and COMP 006) with different dosing regimens and trial structures.plan_implementation
Open slide detailBeat · Roadmap
30
The slide uses a grid-based timeline structure to track progress of clinical trials.plan_implementation
Open slide detailBeat · Roadmap
31
Includes company logo and Nasdaq ticker symbol.front_matter
Open slide detailBeat · Roadmap